Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Cue Biopharma, Inc. has filed 546 SEC EDGAR filings since 19 Jun 2015

SEC filing history

Showing 501-525 of 546 matching filings.

Per page
25
Current page
21
3/A

FORM 3/A SUBMISSION

Filing date
13 Feb 2018
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90232

SCHEDULE 13G

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

FORM 8-K

Filing date
26 Jan 2018
Reporting date
22 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jan 2018
Reporting date
27 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90232

SC 13G

Filing date
09 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Dec 2017
Reporting date
27 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Dec 2017
Reporting date
27 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38327

FORM 8-K

Filing date
27 Dec 2017
Reporting date
27 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
27 Dec 2017
Reporting date
18 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B1 File 333-220550

FINAL PROSPECTUS

Filing date
21 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-222211

FORM S-1MEF

Filing date
21 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-38327

CERT filing

Filing date
18 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-220550

CT ORDER filing

Filing date
15 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-220550

EFFECT filing

Filing date
14 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .